Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. Markets Insider
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times
Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. The Manila Times
Hematometra within a cesarean scar defect in a perimenopausal woman: A case report.
Cesarean scar defect (CSD) is a long-term complication of cesarean section (CS). However, its risks for perimenopausal women remain unclear. We present a rare case of CSD involving hematometra in …
Causal Effect Between Natural Hair Color and Endometriosis in a European Population: A Two-Sample Mendelian Randomization.
Previous observational studies have suggested an association between natural hair color and the risk of endometriosis; however, the causal relationship remains unclear. Here, we conducted a two-sample Mendelian randomization (MR) …
A novel mechanism of FTO modulating the progression of endometriosis through mediating the m6A methylation of GEF-H1 in a YTHDF1-dependent manner.
Endometriosis (EMs) is a condition characterized by the growth of endometrial tissue outside the uterine cavity. Although this condition is benign, it has cancer-like features. N6-methyladenosine (m6A) is a common …